Resolve, to Raise MaineCare Reimbursement Rates for Detoxification Services for Substance Use Disorder Treatment
Summary
LD 514 is a resolve directing the Maine Department of Health and Human Services to amend MaineCare reimbursement rules for substance use treatment facilities. Specifically, it requires the department to update Chapter 101 of the MaineCare Benefits Manual so that non-hospital-based medically supervised withdrawal services are reimbursed at no less than $594.38 per day.
The bill targets the reimbursement framework in Chapter III, Section 97, Private Non-Medical Institution Services, Appendix B, and sets a deadline of January 1, 2026, for the rule change. In practical terms, it would establish a minimum daily MaineCare payment rate for detoxification or withdrawal management services delivered outside a hospital setting.
Impact
If enacted, the resolve would require DHHS to revise MaineCare reimbursement rules and increase the minimum payment rate for non-hospital-based medically supervised withdrawal services. This would directly affect substance use treatment providers that offer detoxification services, particularly private non-medical institutions and other facilities reimbursed under Section 97 of the MaineCare Benefits Manual. The measure would also affect MaineCare spending and could improve provider participation or capacity by setting a higher floor for reimbursement.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or formal support/opposition in the available record. Based on the bill’s sponsor and cosponsors, the measure appears to have been introduced with support from legislators concerned about substance use treatment access and provider reimbursement. The overall framing of the bill is policy-oriented and remedial, focusing on increasing payment rates rather than restricting services.
Contention
The main likely point of contention is fiscal impact: raising the minimum MaineCare reimbursement rate could increase state Medicaid costs. Another possible issue is whether the specified rate of $594.38 per day is the appropriate level and whether a statutory or resolve-based mandate is the best way to set reimbursement policy. Stakeholders most likely to support the bill are detoxification and substance use treatment providers and advocates for treatment access, while budget-conscious policymakers or administrators may question the cost and implementation requirements.